Jerome D. De Seze-Seze
Strasbourg, 67000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Six-year safety and efficacy outcomes with first-line ofatumumab in recently diagnosed treatment-naive patients with relapsing multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: September 03, 2025
Ozone, NO2 and PM10 are associated with the occurrence of multiple sclerosis relapses. Evidence from seasonal multi-pollutant analyses.
Journal: Environmental research
Published: November 01, 2017
Air pollution by particulate matter PM10 may trigger multiple sclerosis relapses.
Journal: Environmental research
Published: January 04, 2017
Giving meaning to illness: An investigation of self-defining memories in patients with relapsing-remitting multiple sclerosis patients.
Journal: Consciousness and cognition
Published: April 25, 2016
Neuromyelitis optica spectrum disorder (NMOSD): A new concept.
Journal: Revue neurologique
Published: September 06, 2015
Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype.
Journal: Journal of neuroinflammation
Published: November 07, 2014
No evidence for genetic association between glutamate transporter EAAT2 and Devic's neuromyelitis optica in caucasians and afro-caribbeans.
Journal: Multiple sclerosis and related disorders
Published: November 06, 2012
Magnetic resonance spectroscopy evaluation in patients with neuromyelitis optica.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: April 03, 2010
Recurrent inflammatory optic neuritis and neuromyelitis optica
Journal: Revue neurologique
Published: March 03, 2010
Last Updated: 09/26/2026